CRPC with Bone Metastases: From the Editor
From the Desk of the Editor: Non-Metastatic Metastases and Other Confusing Findings from the PROSPER and SPARTAN Trials
From the Desk of the Editor: “Bone Metastases Matter”
Normally, we can see this coming – both in terms of the symptoms progressing through the last year or year and a half of life, as well as the tumor burden. Until recently, it has been hard to quantify these factors.
Bone is the New Primary - Daniel George
In the past, I would smile politely and correct them by saying, “actually what you have is prostate cancer that has spread to your bones.” But, what if they are right? I mean, many of these patients have previously undergone a prostatectomy or radiation therapy, and have no evidence of local disease. Sure, the patient may have an elevated prostate-specific antigen (PSA) level, but does that alone really make this prostate cancer?